Newcastle Disease Virus Archive | IOZK

Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade

2020-08-07/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2020-08-07 / Cancer Cell Int. 2020;20:380

Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways

2020-08-07/in Cervical Cancer, International Publications, Newcastle Disease Virus /von 2020-08-07 / Microb. Pathog. 2020 Aug;147:104438

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit

2020-07-23/in Dendritic Cells, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-07-23 / Biomedicines 2020 Jul;8(8)

Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets

2020-07-07/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2020-07-07 / Cancers (Basel) 2020 Jul;12(7)

Oncolytic Viral Therapy for Malignant Pleural Mesothelioma

2020-07-01/in International Publications, Malignant Pleural Mesothelioma, Newcastle Disease Virus /von 2020-07-01 / J Thorac Oncol 2020 Jul;15(7):e111-e113

Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies

2020-06-30/in Dendritic Cells, Hyperthermia, International Publications, Newcastle Disease Virus /von 2020-06-30 / Expert Rev Anticancer Ther 2020 Jun;:1-8

Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo

2020-06-29/in Colorectal Cancer, International Publications, Newcastle Disease Virus /von 2020-06-29 / Cancer Cell Int. 2020;20:278

Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion

2020-06-05/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2020-06-05 / Cells 2020 Jun;9(6)

Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses

2020-05-14/in International Publications, Newcastle Disease Virus /von 2020-05-14 / Gene Ther. 2020 May;

New Insights into Mechanisms of Long-term Protective Anti-tumor Immunity Induced by Cancer Vaccines Modified by Virus Infection

2020-03-06/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2020-03-06 / Biomedicines 2020 Mar;8(3)